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Summary
The antigen-specific binding of T cells to antigen presenting cells results in recruitment of signalling proteins to microclusters at the cell-
cell interface known as the immunological synapse (IS). The Vav1 guanine nucleotide exchange factor plays a critical role in T cell
antigen receptor (TCR) signalling, leading to the activation of multiple pathways. We now show that it is recruited to microclusters and
to the IS in primary CD4+ and CD8+ T cells. Furthermore, we show that this recruitment depends on the SH2 and C-terminal SH3
(SH3B) domains of Vav1, and on phosphotyrosines 112 and 128 of the SLP76 adaptor protein. Biophysical measurements show that
Vav1 binds directly to these residues on SLP76 and that efficient binding depends on the SH2 and SH3B domains of Vav1. Finally, we
show that the same two domains are critical for the phosphorylation of Vav1 and its signalling function in TCR-induced calcium flux.
We propose that Vav1 is recruited to the IS by binding to SLP76 and that this interaction is critical for the transduction of signals leading
to calcium flux.
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Introduction
Antigen-specific activation of T cells is triggered by the binding
of the cell surface T cell antigen receptor (TCR) to antigenic
peptide bound to MHC molecules (pMHC) on the surface of an
antigen-presenting cell (APC). Initial binding of pMHC to TCR
results in signal transduction from the TCR, leading to activation
of integrins, binding of these adhesion molecules to their counter-
receptors on the APC and hence the formation of a stable T
cell:APC conjugate. The cell-cell interface of this integrin-
stabilised conjugate has been termed the immunological synapse
(IS) (Dustin et al., 2010; Dustin et al., 1998). In some cases the IS
is characterised by an ordered arrangement of proteins, with a
central accumulation of TCR molecules surrounded by a ring
of integrins in zones known as the central and peripheral
supramolecular activation clusters (cSMAC and pSMAC)
respectively (Monks et al., 1998). Imaging of signalling
proteins has shown that these also segregate within the IS,
with, for example, PKCh and talin found in the cSMAC and
pSMAC respectively. Kinetic analysis of T cells interacting with
pMHC and integrin ligands presented on supported lipid bilayers
has shown that within seconds of ligand engagement, the TCR
forms microclusters in the periphery of the IS which then move to
the centre of the synapse over the course of several minutes to
form the cSMAC (Campi et al., 2005; Grakoui et al., 1999;
Yokosuka et al., 2005). Signalling molecules such as the ZAP70
kinase and the LAT and SLP76 adaptors are also recruited to
microclusters within the IS, and these too migrate centripetally,
though they dissociate before reaching the cSMAC (Yokosuka
et al., 2005). Studies have shown that active signalling occurs in
the peripheral microclusters, but is usually extinguished within
the cSMAC, which may be an area from which TCR molecules
are internalised (Campi et al., 2005; Grakoui et al., 1999;
Mossman et al., 2005; Varma et al., 2006). TCR microclusters
have also been observed in an alternative imaging system where
T cells interact with antibodies to the TCR and, in some cases to
CD28, immobilised on glass (Barda-Saad et al., 2005; Braiman
et al., 2006; Bunnell et al., 2002; Bunnell et al., 2001). In these
studies, the TCR microclusters form but are unable to move
because they are bound by immobilised anti-CD3 antibodies, and
thus the system is best used to study the initial TCR proximal
signalling events (Bunnell et al., 2002; Bunnell et al., 2006).
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Finally, live cell 3D imaging of 30 different signalling sensors in
T cells conjugated to APCs has shown a diverse range of
spatiotemporal patterning, which may be important for efficient T
cell activation (Singleton et al., 2009).
Vav1 is a guanine nucleotide exchange factor (GEF) for Rho
family GTPases (Tybulewicz, 2005), which plays an important
role in TCR signalling, transducing signals that lead to an
increase in intracellular Ca2+ (calcium flux), and the activation of
Fig. 1. See next page for legend.
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ERK MAP kinases, phosphoinositide-3-kinase (PI3K), the Akt
kinase, and the transcription factors nuclear factor kB (NF-kB)
and nuclear factor of activated T cells (NFAT) (Costello et al.,
1999; Fischer et al., 1998; Holsinger et al., 1998; Reynolds et al.,
2004; Reynolds et al., 2002; Tybulewicz, 2005). Vav1 is also
required to transduce signals leading to integrin activation and
cytoskeletal rearrangements, and cell polarisation (Ardouin et al.,
2003; Fischer et al., 1998; Holsinger et al., 1998; Krawczyk et al.,
2002; Wu¨lfing et al., 2000).
Structural analysis of Vav1 has shown that it contains multiple
domains (Fig. 2A). The GEF activity of Vav1 resides in the Dbl
homology (DH) domain, which is tightly associated with
pleckstrin homology (PH) and C1 domains, forming a catalytic
core (Chrencik et al., 2008; Rapley et al., 2008). N-terminal to
these are a calponin homology (CH) domain and an acidic region
that negatively regulate the GEF activity of Vav1 by binding to
the DH and PH domains and sterically blocking binding of the
GTPase substrates (Aghazadeh et al., 2000; Yu et al., 2010).
Phosphorylation of tyrosine residues located within the acidic
domain leads to dissociation of the CH and acidic domains from
the DH-PH-C1 catalytic core of Vav1 and hence increased
enzymatic activity (Aghazadeh et al., 2000; Yu et al., 2010). C-
terminal to the DH-PH-C1 domains of Vav1, the protein contains
one SH2 domain and two SH3 domains (SH3A, SH3B),
suggesting that Vav1 may function as an adaptor as well as a
GEF. Recently we showed that the GEF activity of Vav1 is
important for some but not all of its functions. In T cells
expressing a GEF-deficient Vav1, TCR-induced activation of
Rac1, Akt and integrins is defective (Saveliev et al., 2009). In
contrast, TCR-induced calcium flux, ERK activation and cell
polarisation are not affected by this GEF mutation, demonstrating
that Vav1 has GEF-independent functions, potentially as an
adaptor protein.
Vav1 has been reported to associate with a number of other
signalling proteins in T cells (Tybulewicz, 2005). Through its
SH2 domain Vav1 can bind to phosphotyrosine (pY) 315 on the
ZAP70 kinase, an interaction that may be required for subsequent
phosphorylation of Vav1 by ZAP70 (Katzav et al., 1994; Wu
et al., 1997). Additionally, the SH2 domain of Vav1 has been
reported to bind phosphotyrosine pY112 and pY128 of SLP76
(numbering given for mouse SLP76, corresponding to Y113 and
Y128 in human SLP76), an adaptor protein critical for TCR
signalling (Fang and Koretzky, 1999; Koretzky et al., 2006;
Tuosto et al., 1996; Wu et al., 1996). The SH3A domain of Vav1
can bind to an SH3 domain of the Grb2 adaptor protein through
an atypical SH3-SH3 interaction (Nishida et al., 2001), and may
also bind an SH3 domain of Nck1 by a similar mechanism
(Barda-Saad et al., 2010). In addition, Vav1 associates with the
Itk kinase, though the Vav1 domains required for this are
unknown (Bunnell et al., 2000; Dombroski et al., 2005).
The recruitment of TCR proximal signalling molecules to
microclusters at the IS, and the documented association of Vav1
with some of these, has led to the expectation that Vav1 may also
move to the IS. Biochemical and imaging studies in the Jurkat T
cell leukaemic cell line and in mouse CD4+ T cells have shown
that Vav1 is located in the cytoplasm in resting cells, but
recruited to the plasma membrane following TCR stimulation
and to the IS in T cell:APC conjugates (Groysman et al., 2002;
Miletic et al., 2006; Singleton et al., 2011; Sylvain et al., 2011;
Tamir et al., 2000; Villalba et al., 2001; Xavier et al., 1998; Zeng
et al., 2003; Zhang et al., 1998). However no studies to date have
examined the localisation of Vav1 in CD8+ T cells. In this study,
using primary CD4+ and CD8+ T cells, we show that Vav1
redistributes to the IS in conjugates and to microclusters
following TCR stimulation, we identify that the SH2 and SH3B
domains of Vav1 are required for this movement, and show that
the recruitment depends on Y112 and Y128 of SLP76.
Furthermore, we show that the SH2 and SH3B domains of
Vav1 are also required for its phosphorylation and subsequent
activation of GEF activity, and for TCR-induced calcium flux,
thereby demonstrating that both the GEF-dependent and
-independent signalling functions of Vav1 require its correct
localisation.
Results
Vav1 is recruited to the immunological synapse in both
CD4+ and CD8+ primary T cells
To investigate the recruitment of Vav1 to the synapse in primary
CD4+ T cells we used DO11.10 TCR transgenic T cells, which
are specific for an ovalbumin peptide (OVA323-339) presented
on I-Ad (Murphy et al., 1990). Activated DO11.10 T cells were
mixed with primary B cells from Vav1-deficient mice as antigen-
presenting cells (APCs) that had been pulsed with OVA peptide
to induce formation of T cell:APC conjugates. We used Vav1-
deficient APCs so that an anti-Vav1 antibody would detect Vav1
only in T cells. Cells were fixed at different time points and
stained with antibodies against phosphotyrosine (a mark of
active signalling) and against Vav1, and imaged by confocal
microscopy. Analysis showed clear accumulation of both
phosphotyrosine and Vav1 at the immunological synapse (IS)
between the T cells and the APCs (Fig. 1A–C). Similarly, we
analysed recruitment of Vav1 to the IS in CD8+ T cells using F5
TCR transgenic T cells, which are specific for the NP68 peptide
presented on H-2Db (Mamalaki et al., 1993). Once again,
activated F5 T cells were mixed with primary B cells from
Vav1-deficient mice as APCs that had been pulsed with NP68
Fig. 1. Localisation of Vav1 in primary CD4+ and CD8+ T cells.
(A,B,C) Activated CD4+ DO11.10 T cells conjugated with APCs (B cells
from BALB/c-Vav12/2 mice) loaded or not with the OVA peptide.
(D,E,F) Activated CD8+ F5 T cells conjugated with APCs (B cells from
129S8-Vav12/2 mice) loaded or not with the NP68 peptide. (A,D) Images
show single optical sections of T cell:APC conjugates stained with antibodies
against phosphotyrosine (pY) and Vav1, as well as DIC images. APCs are
indicated with asterisks. Scale bar: 10 mm. (B,E) Recruitment index (mean
6SEM) of pY and Vav1 in the T cells, a measure of polarisation towards the
IS, quantified from images such as those shown in (A) and (D), either in
conjugates generated in the absence of cognate peptide, or after 5–40 min of
conjugate formation, as indicated. n indicates the number of cells scored for
each time point. (C) and (F) Percentage of T cells showing accumulation of
pY and Vav1 towards the IS. (G) CD4+ DO11.10 or CD8+ F5 T cells
expressing EGFPVav1 were conjugated for 7 min with OVA peptide-pulsed
or NP68-pulsed APCs (B cells from Vav12/2 mice). Images show single
optical sections of T cell:APC conjugates stained with antibodies against
EGFP and phosphotyrosine (pY), as well as phase images. APCs are indicated
with asterisks. Scale bar: 5 mm. (H,I) (H) 5C.C7 CD4+ T cells expressing
EGFPVav1 were conjugated with CH27 cells pulsed with MCC peptide or
(I) P14 CD8+ T cells expressing EGFP-Vav1 were conjugated with B cells
pulsed with gp33 peptide. The graphs display the percentage of cell couples
that displayed accumulation of EGFPVav1 with the indicated patterns as a
function of time relative to formation of tight cell couples (Singleton et al.,
2009). Statistically significant differences were determined with a t-test;
*P,0.05, **P,0.01, ***P,0.001.
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Fig. 2. Correct localisation of mutant Vav1 proteins in F5 CD8+ T cells requires the SH2 and SH3B domains. (A) Schematic representation of EGFPVav1 constructs
used in this study. The mutations in the SH2 (R696A), SH3A (W637Y), and SH3B (W820K) domains of Vav1 and a mutation disabling the putative nuclear localisation
signal (NLS) (K487N R489A K493A) are highlighted with asterisks. (B) CD8+ F5 T cells expressing EGFPVav1 wild-type (WT), SH2, SH3A, SH3B, NLS and
NLS-SH3B mutants were conjugated for 7 min with NP68-pulsed APCs (B cells from 129S8-Vav12/2 mice). Images show single optical sections of T cell:APC conjugates
stained with antibodies against phosphotyrosine (pY) and EGFP, as well as DIC images. APCs are indicated with asterisks. For quantification of the SH3B mutant, the EGFP
signal from the nucleus was digitally subtracted as shown. Scale bar: 5 mm. (C) Graphs showing mean (6SEM) recruitment index of EGFPVav1 quantitated from images
such as those shown in (B). Number of cells analysed (n): WT (75), SH2* (103), SH3A* (76), SH3B* (63), NLS* (74), NLS-SH3B* (66). Statistically significant differences
were determined with a t-test; *P,0.05, **P,0.01, ***P,0.001. (D) Schematic representation of Vav1 proteins with mutations in the DH (LK334AA) and PH
(R422G) domains as highlighted with asterisks. (E) CD8+ F5 T cells expressing WT Vav1 or Vav1 with mutations in the DH or PH domains were conjugated for 7 min with
NP68-pulsed APCs (B cells from 129S8-Vav12/2mice). Images show single optical sections of T cell:APC conjugates stained with antibodies against phosphotyrosine (pY)
and Vav1, as well as DIC images. APCs are indicated with asterisks. Scale bar: 5 mm. (F) Graphs showing mean (6SEM) recruitment index of Vav1 quantitated from images
such as those shown in (E). Number of cells analysed (n): WT (102); DH* (71); PH* (70). The recruitment index in the DH and PH mutants was not significantly (NS)
different to wild-type Vav1.
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peptide to induce formation of T cell:APC conjugates. Image
analysis of conjugates stained with antibodies against both
phosphotyrosine and Vav1 showed that both accumulated at the
IS (Fig. 1D–F). Thus Vav1 is recruited to the IS in both CD4+
and CD8+ primary T cells.
To allow further analysis of the mechanism of recruitment of
Vav1 to the IS, we generated a retroviral vector expressing a
fusion protein between enhanced green fluorescent protein
(EGFP) and Vav1 (EGFP-Vav1). Imaging of DO11.10 CD4+
and F5 CD8+ T cells infected with this viral vector showed that
similar to Vav1, EGFP-Vav1 was also recruited to the IS of
primary CD4+ and CD8+ T cells in peptide specific-conjugates
with APCs, but not in the absence of peptide (Fig. 1G, and data
not shown). Initially we used this fusion protein to image the
movement of Vav1 to the IS in real time, and to classify the
pattern of recruitment in terms of the distribution of Vav1 at the
IS (Singleton et al., 2009). The EGFP-Vav1 expressing retroviral
vector was used to infect 5C.C7 CD4+ or P14 CD8+ T cells and
these were conjugated with APCs pulsed with agonist peptides.
Image analysis of the conjugates was used to define the
distribution of EGFP-Vav1 at the IS as a function of time. This
showed that peak recruitment of EGFP-Vav1 occurred in the first
2 min following conjugate formation and that most of the EGFP-
Vav1 had a peripheral, diffuse or lamellal distribution across the
IS (Fig. 1H,I). EGFP-Vav1 was not found concentrated at
the centre of the IS in either CD4+ or CD8+ T cells. While the
distribution of Vav1 was broadly similar between CD4+ and
CD8+ T cells, the kinetics were somewhat different, with Vav1
persisting for longer at the IS in CD4+ T cells compared to
CD8+ T cells (Fig. 1B,C,E,F,H,I). This may reflect functional
differences between the cell types; in particular, the cytotoxic
responses of CD8+ T cells occur very rapidly, within 4–5 min of
conjugate formation (Stinchcombe et al., 2001). We also note
that while phosphotyrosine was usually found in the peripheral
regions of the IS in CD4+ T cells, it was generally most abundant
centrally in CD8+ T cells, in agreement with previous reports of
active signalling in the cSMAC of CD8+ T cells (Fig. 1A,D)
(Beal et al., 2009; Jenkins et al., 2009; O’Keefe et al., 2004;
Stinchcombe et al., 2001).
The SH2 and SH3B domains of Vav1 are required for
recruitment to the immunological synapse
Next we used the EGFP-Vav1 protein to determine which
domains of Vav1 were required for recruitment to the IS. We
generated retroviral vectors expressing EGFP-Vav1 with point
mutations in the SH2, SH3A and SH3B domains (Fig. 2A). The
R696A mutation (SH2*) abolishes the ability of the SH2 domain
of Vav1 to bind phosphotyrosine containing peptides; the W637Y
mutation (SH3A*) abolishes binding of the SH3A domain of
Vav1 to the C-terminal SH3 domain of Grb2 (Nishida et al.,
2001); the W820K mutation (SH3B*) abolishes the ability of the
SH3B domain of Vav1 to bind poly-proline motifs in target
proteins. Expression of these mutant EGFP-Vav1 proteins in
CD8+ F5 T cells showed that mutation of the SH2 domain
strongly reduced recruitment of the protein to the IS (Fig. 2B,C).
Mutation of the SH3B domain also decreased recruitment, but the
effect was only partial. In contrast the SH3A mutation had no
effect on recruitment to the IS. The SH2 domain of EGFP-Vav1
was also required for recruitment to the IS of CD4+ primary T
cells as shown by imaging of conjugates between DO11.10 or
5C.C7 T cells and agonist peptide-pulsed APCs (Fig. 3A–D).
In imaging the SH3B* mutant EGFP-Vav1, we noticed that
much of the protein was in the nucleus, in contrast to wild-type
Vav1 (Fig. 2B). Earlier studies had shown that deletion of the
SH3B domain of Vav1 caused the protein to move into the
nucleus (Houlard et al., 2002). In this work, the authors had
defined a nuclear localisation signal (NLS) in the PH domain of
Vav1. We wondered if the reduced recruitment of EGFP-Vav1-
SH3B* to the IS might be due to localisation of some of the
protein to the nucleus, rather than a direct role for the SH3B
domain in IS recruitment. To address this, we designed a novel
mutation to inactivate the NLS. Previous work had deleted eight
Fig. 3. The SH2 domain of Vav1 is required for correct
localisation in CD4+ T cells. (A) Schematic representation of
EGFPVav1 WT and SH2 mutant constructs used in this study. The
SH2 mutation is highlighted with an asterisk. (B) CD4+ DO11.10
T cells expressing WT Vav1 or Vav1 with a mutation in the SH2
domain were conjugated for 7 min with OVA peptide-pulsed
APCs (B cells from BALB/c-Vav12/2 mice). Images show single
optical sections of T cell:APC conjugates stained with antibodies
against phosphotyrosine (pY) and EGFP, as well as DIC images.
APCs are indicated with asterisks. Scale bar, 5 mm. (C) Graph
showing mean (6SEM) recruitment index of EGFPVav1
quantitated from images such as those shown in (B). Number of
cells analysed: WT (50), SH2* (57). (D) Graph showing mean
(6SEM) recruitment index of EGFPVav1 in 5C.C7 CD4+ T cells
conjugated with CH27 B cell lymphoma APCs pulsed with 10 mM
MCC agonist peptide, and imaged 5 and 7 min after initiation of
conjugate formation. Number of cell analysed: WT (14), SH2* (11
at 5 min, 7 at 7 min). Statistically significant differences were
determined with a t-test; *P,0.05, **P,0.01.
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amino acids in the NLS; however, several of these residues play a
structural role in the PH domain of Vav1, and thus the mutation
could result in unfolding of the domain, with unpredictable
consequences (Houlard et al., 2002; Rapley et al., 2008). In
contrast, we mutated just three amino acids (K487N, R489A,
K493A), which are the only basic residues in the NLS that play
no obvious structural role. When combined with the SH3B*
mutation, this novel NLS mutation (NLS*) abolished localisation
of EGFP-Vav1-SH3B* to the nucleus (Fig. 2A,B), thus allowing
study of the SH3B* mutation in the absence of confounding
effects from nuclear localisation. Image analysis of mutant
EGFP-Vav1 proteins in F5 T cell conjugates showed that the
NLS* mutation on its own had no effect on EGFP-Vav1
recruitment to the IS, whereas the double mutant still showed
reduced recruitment (Fig. 2B,C). Thus we conclude that the
SH3B domain of Vav1 is required for normal IS recruitment.
To analyse a potential role for the DH and PH domains of
Vav1 in recruitment to the IS, we made use of mice bearing point
mutations in these domains (Fig. 2D). The L334A K335A
(LK334AA, DH*) mutation abolishes the GEF activity of Vav1
Fig. 4. See next page for legend.
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without perturbing folding of the DH domain (Saveliev et al.,
2009); the R422G mutation (PH*) abolishes binding of
phosphoinositides to the PH domain (Han et al., 1998; Prisco
et al., 2005). Image analysis of F5 CD8+ T cells expressing the
DH* or PH* mutant Vav1 in conjugates with APCs showed that
neither mutation affected recruitment of Vav1 to the IS
(Fig. 2E,F). Taken together we conclude that the SH2 and
SH3B domains of Vav1 are required for normal recruitment to the
IS in primary T cells, whereas the DH, PH and SH3A domains
show no critical role in this process.
The SH2 and SH3B domains of Vav1 are required for
recruitment to microclusters
Next we examined whether Vav1 is recruited to microclusters at
the IS by using total internal reflection fluorescence microscopy
(TIRFM) to image EGFP-Vav1 in CD4+ T cells plated for
3 minutes onto coverslips coated with stimulatory antibodies.
Previous studies had shown the induction of TCR microclusters
in Jurkat T cells plated onto anti-CD3e or in primary T cells
plated onto anti-CD3e and anti-CD28 antibodies (Barda-Saad
et al., 2005; Braiman et al., 2006; Bunnell et al., 2002). Since
Vav1 is phosphorylated in response to stimulation through both
the TCR and CD28 and both TCR and CD28 transduce signals
via Vav1 (Michel et al., 2000; Nunes et al., 1996; Raab et al.,
2001; Tybulewicz, 2005), we compared T cells interacting with
anti-CD3e in the presence or absence of anti-CD28 antibodies.
We found that EGFP-Vav1 is rapidly recruited to microclusters
in cells plated onto anti-CD3e, and the frequency of cells with
Vav1 microclusters, or the size of the clusters was not changed by
inclusion of anti-CD28 (Fig. 4A; supplementary material Movies
1, 2).
Examination of T cells expressing mutant forms of EGFP-
Vav1 showed that the SH2* mutant strongly decreased
recruitment into microclusters as measured by the percentage
of cells showing microclusters of EGFP-Vav1 and the fractional
area occupied by EGFP-Vav1 microclusters (Fig. 4B–D). The
SH3B* mutation also affected recruitment into microclusters,
however the effect was partial as it resulted in decreased
fractional area occupied by EGFP-Vav1 microclusters, but had
no effect on the percentage of cells showing microclusters
(Fig. 4B–D). In contrast, the SH3A* mutation had no effect on
recruitment of EGFP-Vav1 to microclusters (Fig. 4B–D). Thus,
as with recruitment to the IS in general, the specific recruitment
of Vav1 to microclusters also requires the SH2 and, to a lesser
extent, the SH3B domains.
The recruitment of Vav1 to microclusters depends on Y112
and Y128 of SLP76
The SH2 domain of Vav1 has been previously reported to bind
phosphotyrosine (pY) 112 and pY128 of the SLP76 adapter
protein. To examine whether the recruitment of Vav1 to
microclusters at the IS is dependent on the phosphorylation of
these two residues we made use of T cells from SLP762F mice
carrying mutations in SLP76 where both tyrosine residues had
been replaced with phenylalanines (Y112F, Y128F) (Jordan et al.,
2008). SLP762F CD4+ T cells were infected with a retrovirus
expressing EGFP-Vav1 and the recruitment of the fusion protein
was monitored by TIRFM. Analysis showed that while the
SLP762F mutation did not affect the formation of microclusters as
judged by staining for phosphotyrosine, it caused a large
reduction in the recruitment of Vav1 (Fig. 4E–G). If Vav1 is
recruited to microclusters via binding to SLP76, the distributions
of the two proteins should be similar. Indeed TIRFM analysis
showed a very high degree of co-localisation of EGFP-Vav1 and
SLP76 in cells plated onto either anti-CD3e alone or anti-CD3e
with anti-CD28 (Fig. 4H, Pearson’s correlation coefficient,
r50.95960.002 or 0.96060.003, respectively).
Previous studies had shown that mutation of either Y112 or
Y128 of SLP76 abolished the interaction of the adaptor protein
with Vav1 (Fang and Koretzky, 1999). Given that the sequences
surrounding Y112 and Y128 of SLP76 are very similar and both
fit the consensus binding site for the Vav1 SH2 domain
(Songyang et al., 1994), it is not clear why mutation of either
residue alone would lead to loss of Vav1-SLP76 association. One
possible explanation is that there is co-operative binding between
two Vav1 molecules each binding to one pY on SLP76. To
explore this binding further we expressed the SH2 domain
of Vav1 in E.coli, purified it and used isothermal titration
calorimetry (ITC) to assess its ability to bind to peptides from
SLP76 containing pY112, pY128 or both residues (2pY). We
found that the SH2 domain bound to peptides containing either
Fig. 4. Recruitment of Vav1 into microclusters requires the SH2 and
SH3B domains of Vav1 and Y112 and Y128 of SLP76. (A) TIRFM images
of EGFP in CD4+ T cells expressing EGFPVav1. Cells were activated for
3 min on coverslips coated with anti-CD3e 6 anti-CD28 antibodies and
stained for GFP. Scale bar: 5 mm. Graphs show mean (6SEM) percentage of
CD4+ T cells forming EGFPVav1 microclusters and mean (6SEM) area
fraction occupied by microclusters (area of clusters/cell area), calculated only
in cells that formed any microclusters; inclusion of anti-CD28 caused no
significant change in either of these parameters. (B) TIRFM images of EGFP
in CD4+ T cells expressing EGFPVav1-WT, SH2, SH3A or SH3B domain
mutants. Cells were activated for 3 min on coverslips coated with anti-CD3e
and anti-CD28 antibodies and stained for GFP. Scale bar: 5 mm. (C) Mean
(6SEM) percentage of CD4+ T cells forming EGFPVav1 microclusters. Data
are from two independent experiments. Number of cells analysed (n):
EGFPVav1-WT (72), EGFPVav1-SH2* (43), EGFPVav1-SH3A* (73),
EGFPVav1-SH3B* (100). Statistically significant differences were
determined with Fisher’s exact test; ***P,0.001. (D) Mean (6SEM) area
fraction occupied by microclusters, calculated only in cells that formed any
microclusters. Number of cells analysed (n): EGFPVav1-WT (46),
EGFPVav1-SH2* (13), EGFPVav1-SH3A* (33), EGFPVav1-SH3B* (66).
Statistically significant differences were determined with a t-test; **P,0.01,
***P,0.0001. (E) TIRFM images of WT or SLP762F CD4+ T cells
expressing wild-type EGFPVav1. Cells were activated for 3 min on anti-
CD3e and anti-CD28 coated coverslips and stained for GFP or
phosphotyrosine (pY). Scale bar: 5 mm. For SLP762F T cells, example images
are shown of cells without (2ve) and with (+ve) EGFPVav1 microclusters.
(F) Mean percentage of CD4+ T cells (WT or SLP762F) forming EGFPVav1
or phosphotyrosine microclusters. Data are from five (EGFPVav1) and two
(pY) independent experiments. Number of cells analysed (n): WT T cells -
EGFPVav1 (163), pY (67); SLP762F T cells - EGFPVav1 (169), pY (123).
Statistically significant differences were determined with Fisher’s exact test;
***P,0.001. (G) Mean (6SEM) area fraction occupied by microclusters,
calculated only in cells that formed any microclusters. Number of cells
analysed (n): WT T cells – EGFPVav1 (80), pY (39); SLP762F T cells –
EGFPVav1 (15), pY (84). (H) TIRFM images of CD4+ T cells activated for
3 min on coverslips coated with anti-CD3e 6 anti-CD28 antibodies and
stained for GFP or SLP76. The merged images show an overlay of
EGFPVav1 (green) and SLP76 (red) with colocalization visualised by a
yellow colour. Scale bar, 5 mm. Graphs show the mean (6SD) percentage
colocalization of EGFPVav1 with SLP76 and vice-versa. (I) Graph shows
mean (6SEM) dissociation constants (Kd) of binding between the indicated
Vav1 fragments and peptides from SLP76 (pY112, pY128 and 2pY)
determined by isothermal titration calorimetry.
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pY112 or pY128 with a dissociation constant (Kd) of 1640 nM
and 990 nM, respectively (Fig. 4I). The binding of the SH2
domain to a peptide containing both pY112 and pY128 showed a
Kd of 520 nM and a stoichiometry of 2:1 (SH2 domain:peptide),
implying that each pY could independently bind the Vav1 SH2
domain, with a small enhancement of affinity in the two pY
peptide compared to the single pY peptides (Fig. 4I, and data not
shown). There was no detectable binding to a peptide in which
both Y112 and Y128 were unphosphorylated (not shown).
Next we examined the ability of a 3-domain SH3A-SH2-SH3B
fragment of Vav1 to bind to these peptides. Again binding to the
single pY peptides occurred with Kds in the micromolar range
(1846 nM and 1353 nM for the pY112 and pY128 peptides
respectively; Fig. 4I). However binding to the 2pY peptide was
significantly stronger with a Kd of 227 nM, and a stoichiometry
of two SH3A-SH2-SH3B molecules binding to one peptide
(Fig. 4I, and data not shown). Again there was no detectable
binding to an unphosphorylated peptide (not shown). This
enhancement in affinity when using the 3-domain fragment of
Vav1 and the 2pY peptide suggests that there is co-operativity of
binding, perhaps as a result of additional interactions between the
two Vav1 fragments, or between Vav1 and the peptide, outside
the SH2-pY binding pocket, although the latter is unlikely as we
saw no measurable binding with the unphosphorylated peptide.
To identify whether the SH3A or SH3B domains contributed to
this enhanced binding, we measured the affinities of SH3A-SH2
and SH2-SH3B 2-domain fragments for the pY peptides. The
SH3A-SH2 fragment behaved like the isolated SH2 domain with
weaker affinity for the single pY peptides (Kd: 1062 nM and
1043 nM for pY112 and pY128, respectively) and slightly
enhanced binding to the 2pY peptide (Kd: 579 nM) (Fig. 4I). By
contrast, the SH2-SH3B fragment behaved similarly to the 3-
domain fragment with weaker binding to the single pY peptides
(Kd: 1325 nM and 1062 nM for pY112 and pY128, respectively),
but strongly enhanced binding to 2pY (Kd: 111 nM) (Fig. 4I).
Once again the stoichiometry of the interaction was 2 Vav1
fragments to one 2pY peptide (not shown). These results show
that the SH2 domain of Vav1 binds to both pY112 and pY128 of
SLP76, and that the binding of two Vav1 molecules to the 2pY
peptide of SLP76 is enhanced by the presence of the SH3B
domain.
The SH2 and SH3B domains of Vav1 are required for its
phosphorylation
Next we examined the functional consequences of recruitment of
Vav1 to microclusters at the IS. Vav1 is phosphorylated on
tyrosine residues following TCR stimulation, a process required
for full activation of its GEF activity (Tybulewicz, 2005). To
evaluate the effects of domain mutations on phosphorylation of
Vav1, we used retroviral infection to express wild-type and
mutant EGFP-Vav1 in primary CD4+ T cells, and then examined
TCR-induced phosphorylation of the fusion protein. We found
that the SH2* mutation caused a complete loss of tyrosine
phosphorylation of EGFP-Vav1 (Fig. 5A). In contrast, mutation
of the SH3A domain had no effect, whereas the SH3B* mutation
caused a partial reduction in phosphorylation (Fig. 5B). In
previous studies we had shown that the PH* and DH* mutations
did not affect tyrosine phosphorylation of Vav1, suggesting that
the function of these domains is not critical for this process
(Prisco et al., 2005; Saveliev et al., 2009). Thus the same
Fig. 5. TCR-induced
phosphorylation of Vav1 requires
intact SH2 and SH3B domains.
Immunoblots of anti-Vav1
immunoprecipitates and total cell
lysates of CD4+ T cells transduced
with (A) no virus, or virus expressing
WT or SH2 mutant EGFPVav1, or
(B) with viruses expressing WT, SH3A
and SH3B mutants of EGFPVav1. The
cells were stimulated with anti-CD3e
and anti-CD28 antibodies for the
indicated times, and the immunoblots
were probed with antibodies to Vav1,
pY, Erk2 and pErk2 as indicated.
Graphs show mean (6SEM)
percentage phosphorylation of
EGFPVav1, from at least two
independent experiments.
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mutations in the SH2 and SH3B domains that, respectively,
completely or partially reduce recruitment to the IS and to
microclusters, also cause complete or partial loss of
phosphorylation, suggesting that recruitment of Vav1 to the IS
through these domains is required for phosphorylation, and hence
for activation of GEF activity.
The SH2 and SH3B domains of Vav1 are required for TCR-
induced calcium flux
In addition to its GEF-dependent functions, Vav1 also has GEF-
independent functions transducing TCR signals to calcium flux.
Previous studies had indicated that Vav1 is required for TCR-
induced activation of PLCc1 and hence to the production of
inositol-3,4,5-trisphosphate (IP3), a second messenger that
triggers release of Ca2+ from intracellular stores (Reynolds
et al., 2002). As expected from these earlier observations, Vav1-
deficient CD4+ and CD8+ T cells show a defective TCR-induced
calcium flux, when cells were stimulated in the presence of
EGTA to chelate extracellular calcium and thus limit the calcium
flux to release from intracellular stores (Fig. 6A).
To evaluate whether mutations in the SH2 or SH3 domains
perturb this function of Vav1, we used retroviral infection to
express wild-type or mutant EGFP-Vav1 proteins in Vav1-
deficient CD4+ T cells. Once again we found that mutation of the
SH3A domain had no effect, mutation of the SH3B domain
partially reduced TCR-induced calcium flux, whereas the SH2*
mutation resulted in no increase in calcium flux above that seen
in Vav1-deficient T cells (Fig. 6B,C). To understand whether the
reduced calcium flux in T cells expressing the SH3B* mutant
was due to its partial nuclear localisation, or to a cytoplasmic
function for this domain, we also compared the TCR-induced
calcium flux in Vav1-deficient T cells expressing the NLS* and
NLS*-SH3B* mutant EGFP-Vav1. These studies show that the
NLS* mutation does not affect TCR-induced calcium flux,
whereas the NLS*-SH3B* mutant is once again partially
compromised (Fig. 6C). In conclusion, as with recruitment to
the IS and with TCR-induced phosphorylation, the SH2 domain
is critical for the ability of Vav1 to transduce TCR signals to the
rise in intracellular calcium, while the SH3B domain plays a more
minor, yet detectable, role.
Discussion
We have shown that, in common with many other signalling
molecules that transduce proximal TCR signals, Vav1 is recruited
to the IS of primary CD4+ and CD8+ T cells. Dynamic imaging of
both 5C.C7 CD4+ and P14 CD8+ T cells showed that Vav1 was
Fig. 6. The SH2 and SH3B domains of Vav1 are required for normal TCR-induced calcium flux. (A) Graphs show mean ratio of Indo-1 violet/blue
fluorescence, a measure of intracellular Ca2+ as a function of time in Vav1+/+ (green) or Vav12/2 (black) CD4+ or CD8+ T cells in the presence of EGTA to chelate
extracellular calcium, thus limiting calcium flux to release from intracellular stores. The time at which cells were stimulated with crosslinking antibody is
indicated by a vertical arrow. (B,C) Vav1-deficient CD4+ T cells were transduced with (B) retroviruses expressing EGFPVav1 WT or SH2*, SH3A* and SH3B*
mutants, or with (C) retroviruses expressing EGFP-WT, or NLS*, SH3B* and NLS-SH3B* mutants. Inset histograms show EGFP expression in T cells transduced
with retroviruses expressing EGFPVav1 WT protein, and markers show gates used to distinguish GFP+ and GFP2 cells. Graphs show mean ratio of Indo-1 violet/
blue fluorescence, a measure of intracellular Ca2+ as a function of time in Vav1-deficient CD4+ T cells expressing indicated constructs and gated as on histograms.
To demonstrate the calcium flux in Vav1-deficient T cells, GFP2 cells are shown from cultures infected with a virus expressing EGFP Vav1 WT. In all other
cases, only GFP+ cells are shown. The time at which cells were stimulated with crosslinking antibody is indicated by a vertical arrow. One representative
experiment out of three is shown.
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localised predominantly to the periphery of the IS or diffusely
across the cell-cell interface, corresponding most closely to the
pSMAC distribution. A similar distribution was also seen in
DO11.10 CD4+ T cells where the distribution of Vav1 was most
closely correlated to that of F-actin and active Cdc42 (Singleton
et al., 2011). Furthermore, in CD4+ T cells Vav1 was found in
microclusters at the plasma membrane following stimulation with
immobilised anti-CD3e in the presence or absence of anti-CD28
antibodies. This recruitment to the IS and to microclusters was
completely dependent on the SH2 domain of Vav1 and partially
dependent on a functional SH3B domain. In contrast we found no
requirement for the DH, PH or SH3A domains. Furthermore, we
showed that Vav1 recruitment to microclusters was dependent on
Y112 and Y128 of SLP76, suggesting that this may be due to
direct binding of the Vav1 SH2 domain to these residues once
they become phosphorylated. Such an interpretation was
supported by a high degree of co-localisation of Vav1 and
SLP76 in microclusters. In addition, biophysical studies showed
that the SH2 domain of Vav1 binds to both pY112 and pY128,
that a doubly phosphorylated peptide can recruit two Vav1 SH2
domains, and that this binding was strongly enhanced by the
presence of the SH3B domain. This cooperative binding of two
Vav1 molecules to one SLP76 molecule potentially explains why
both the SH2 and SH3B domains of Vav1 are required for
recruitment to the IS and to microclusters, and may also explain
the observation that mutation of either Y112 or Y128 causes loss
of Vav1-SLP76 association, despite the ability of the Vav1 SH2
domain to bind to either phosphotyrosine (Fang and Koretzky,
1999).
In some PH domain-containing proteins the PH domain binds
phosphoinositides and this interaction is required for membrane
recruitment (Lemmon, 2008). The PH domain of Vav1 also binds
phosphoinositides (Han et al., 1998), however our data show that
this binding is not required for recruitment to the IS. Our results
agree with a recent study in Jurkat T cells, which showed that the
SH2 domain of Vav1 is required for its recruitment to SLP76-
containing microclusters and that mutation of the SH3B domain
partially inhibits this movement (Sylvain et al., 2011). In contrast
to our results, the same study also found a partial role for the
SH3A domain in this recruitment. The reason for this discrepancy
is unknown, but may be due to differences between Jurkat cells
and primary mouse T cells, or to the use of a different mutation
(P657A), though we note that both this mutation and the one we
have used (W637Y) are predicted to abolish binding to the SH3
domain of Grb2 (Nishida et al., 2001). In another study in Jurkat
cells, the binding of Vav1 to SLP76 was abrogated by mutations
in Y112 and Y128 of SLP76, in agreement with our data in
primary T cells (Barda-Saad et al., 2010). However the same
study showed that in Jurkat cells association of Vav1 with SLP76
was dependent on the adaptor protein Nck. The authors proposed
that through its SH2 domain, Nck binds to pY112 and pY128 on
SLP76, and through its C-terminal SH3 domain binds to the
SH3A domain of Vav1, thereby bridging the binding of SLP76
and Vav1. Such a model predicts that the SH3A domain of Vav1
is important for its recruitment, but provides no role for the SH2
domain in this process, in contrast to our results. It is certainly
possible that a Vav1-Nck-SLP76 complex is formed in T cells,
stabilised by multiple domain interactions, however the lack of
any effect of the SH3A mutation on Vav1 recruitment suggests
that in primary mouse T cells the Vav1-Nck interaction may be
less critical for the movement of Vav1.
Our studies showed that mutation of a single amino acid in the
SH3B domain (W820K) causes a large fraction of Vav1 to
localise to the nucleus. This is similar to results in a previous
study showing that deletion of SH3B causes Vav1 to move to the
nucleus of RBL-2H3 cells, a mast cell line (Houlard et al., 2002).
In this study the authors had defined an eight amino acid NLS
located within the PH domain that was required for nuclear
localisation. Inspection of the structure of Vav1 showed that
some of these eight residues are probably important for the
stability of the PH domain, and thus their mutation, a deletion of
all eight amino acids, may perturb functions other than just
nuclear localisation. In the present study we show that mutation
of just three amino acids (K487N, R489A, K493A) located on the
surface of the PH domain was able to block entry of Vav1 into
the nucleus, thereby more precisely defining the NLS. This more
restricted mutation may be useful in defining the physiological
role of Vav1 in the nucleus, about which little is currently known,
though a nuclear localisation of Vav1 has been reported in
several studies (Bertagnolo et al., 1998; Blanchet et al., 2005;
Brugnoli et al., 2010; Clevenger et al., 1995; Romero et al., 1996;
Romero et al., 1998). The dramatic change in Vav1 localisation
to the nucleus in the SH3B* point mutant suggests that this
domain is binding a cytoplasmic protein, which retains Vav1 in
the cytoplasm, perhaps through a canonical SH3-polyproline
interaction. Alternatively, the SH3B domain may bind to
sequences in Vav1 resulting in a conformation that masks the
NLS, as previously suggested (Houlard et al., 2002). A 3D
structure of the whole of Vav1 would help address this
possibility.
Mutations in the SH2 and SH3B domains of Vav1 fully or
partially inhibit its TCR-induced phosphorylation, suggesting
that correct localisation of Vav1 is critical for this GEF-activating
modification. The reverse possibility, that phosphorylation is
required for correct localisation, is unlikely because mutation of
all three tyrosine phosphorylation sites (Y142, Y160, Y174) did
not affect recruitment of Vav1 to microclusters in Jurkat cells
(Sylvain et al., 2011). Defective phosphorylation of the SH2*
mutant might be caused by failure of Vav1 to bind to pY315 on
ZAP70 and hence to be phosphorylated by the kinase.
Alternatively, the reduced phosphorylation could be caused by
failure to bind to SLP76, which in turn may be required to bring
Vav1 close to the kinase that phosphorylates it. In agreement with
this, TCR-induced Vav1 phosphorylation is reduced in SLP762F
thymocytes (Jordan et al., 2008). Such a possibility would also
explain the partial requirement for the SH3B domain, since this
domain is required for high affinity binding to SLP76.
Finally, we showed that mutations in the SH2 and SH3B
domains fully or partially inhibit TCR-induced calcium flux. This
signalling pathway depends on Vav1 most likely because Vav1 is
required for the phosphorylation of PLCc1 and its subsequent
activation, as judged by reduced TCR-induced IP3, a second
messenger which leads to calcium flux by triggering release of
calcium from intracellular stores (Fig. 6A) (Reynolds et al.,
2002). We and others have shown that in primary mouse T cells
this function of Vav1 is independent of its GEF activity (Miletic
et al., 2009; Saveliev et al., 2009), a finding recently corroborated
in Jurkat T cells (Sylvain et al., 2011). This GEF-independent
function of Vav1 has been proposed to be as an adaptor protein,
stabilising the binding of PLCc1 to the LAT/SLP76 complex,
which in turn binds the Itk kinase that phosphorylates PLCc1.
Our results indicate that through its SH2 domain, Vav1 binds to
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SLP76, a binding that is enhanced by the SH3B domain, the same
two domains that are required for a normal TCR-induced calcium
flux. In view of this, we propose that the binding of Vav1 to
SLP76 is critical for the TCR-induced activation of PLCc1,
leading to calcium flux. In agreement with our data, a recent
study in Jurkat T cells also implicated the SH2 and SH3B
domains in this pathway (Sylvain et al., 2011). In addition, the
same study identified that the CH domain and possibly other N-
terminal domains may contribute to this adaptor function for
Vav1. The mechanism by which these several domains of Vav1
contribute to the activation of PLCc1 is an area for future study.
In summary, we have shown that in primary mouse T cells,
Vav1 is recruited to the IS and to microclusters via SLP76, we
have identified domains required for this localisation and we
show that this recruitment is essential for both its GEF-dependent
and -independent functions.
Materials and Methods
Mice
Mice carrying a mutation disrupting Vav1 (Vav1tm1Tyb/tm1Tyb; Vav12/2) on a
129S8 or BALB/c background, or mutations in the PH (Vav1tm2Tyb/tm2Tyb;
Vav1R422G/R422G) and DH (Vav1tm4Tyb/tm4Tyb; Vav1) domains of Vav1 have been
described previously (Prisco et al., 2005; Saveliev et al., 2009; Turner et al., 1997).
Mice carrying the Y112F,Y128F mutation in the Lcp2 gene, which encodes for
SLP76, were described previously (SLP762F) (Jordan et al., 2008). Transgenic
mice expressing the F5, DO11.10, 5C.C7 and P14 TCRs have been described
previously (Mamalaki et al., 1993; Murphy et al., 1990; Pircher et al., 1989; Seder
et al., 1992). Mice bearing the F5 and DO11.0 TCRs were crossed onto a
background deficient in Rag1 (Rag1tm1Bal/tm1Bal) (Spanopoulou et al., 1994). All
animal experiments were performed following approval by the local Ethical
Review Process of the MRC National Institute for Medical Research and
authorisation by the UK Home Office under relevant Project Licence authority.
Generation of bone marrow chimeras
Bone marrow cells from C57BL/6J or SLP762F mice were injected intravenously
into C57BL/6J-Rag1tm1Mom/tm1Mom male mice previously irradiated with 5 Gy
from a 137Cs source. T cells from these mice were used 6 or more weeks after
reconstitution.
DNA constructs
To generate a fusion protein between enhanced green fluorescent protein (EGFP)
and mouse Vav1, the complete open reading frame of EGFP without the stop
codon was taken from pEGFP-C1 (Clontech) and joined to the 59 end of the
complete mouse Vav1 cDNA including a stop codon, with a linker between the
two consisting of the sequence AGTACTGGA, encoding the amino acids Ser-Thr-
Gly. This EGFP-Vav1 fusion open reading frame was cloned into an EcoRI site in
the pMSCV retroviral vector to generate pMSCV-EGFP-Vav1. Mutations in Vav1
were introduced into this construct using standard methods.
Cell culture
To isolate F5 CD8+ T cells, lymph nodes and spleens from F5 transgenic mice were
mechanically disrupted, and erythrocytes were removed from splenocyte preparations
by lysis with ACK buffer (0.15 M NH4Cl, 1 mM KHCO3, 0.1 mM EDTA). To induce
activation, F5 T cells were cultured at a concentration of 16106 cells/ml with 10 nM
NP68 peptide for 72 h in T cell medium [RPMI-1640, 10% fetal calf serum, 10,000 U/
ml penicillin, 10 mg/ml streptomycin, 2 mM L-glutamine (Sigma), non essential
amino acids (Gibco), 10 mM HEPES (Gibco) and 50 mM 2-mercaptoethanol
(Gibco)]. Dead cells were removed using Lympholyte-M (Cedarlane Laboratories)
according to the manufacturer’s protocol. Viable lymphocytes were cultured for a
further 96 h at 0.26106 cells/ml in T cell medium with 15 ng/ml IL-2 (Peprotech) after
which they were used for conjugate formation experiments. DO11.10 CD4+ T cells
from lymph nodes were prepared as described above and activated by co-culturing
16106 DO11.10 CD4+ T cells for 72 h in T cell medium with 26106 BALB/c
splenocytes that had been previously irradiated (300 rads) and loaded with OVA323–339
peptide (final concentration 0.25 mM). Subsequently, T cells (16106 cells/ml) were
cultured with IL-2 (5 ng/ml) for 96 h and used for conjugate formation experiments.
CD4+ T cells from wild-type, Vav12/2 animals or radiation chimeras reconstituted
with wild-type or SLP762F/2F bone marrow, were isolated from lymph nodes and
purified by negative selection (Dynabeads) using anti-CD8, anti-B220 and anti-Mac1
antibodies. Purity was checked by flow cytometry and was typically in the range of
80–90%. 26106 purified CD4+ T cells were activated by plate-bound anti-CD3e (2C11
clone) and anti-CD28 (37.51 clone) antibodies at concentration 1.5 mg/ml for WT cells
and at 3 mg/ml for Vav12/2 T cells for 72 h in T cell medium. Subsequently, cells
were cultured (0.7–16106 cells/ml) with IL-2 (15 ng/ml) for 96 h. Vav1-deficient B
cells used as APCs in conjugate formation experiments, were isolated from the spleens
of 129S8-Vav12/2 or BALB/c-Vav12/2mice by negative selection (Dynabeads) using
anti-CD43 and anti-TCRb antibodies. Purity was typically 85–95%.
Retroviral production and transduction
To produce retrovirions, the ecotropic packaging cell line PlatE (Morita et al.,
2000) was transfected with DNA encoding pMSCV1-based vectors and GeneJuice
(Novagen) according to the manufacturer’s instructions. Supernatant from
transfected cells was collected 48 h and 72 h after transfection, filtered through
0.45-mm filters to remove cell debris, concentrated by centrifugation (15,000 g,
2 h, 4 C˚) and resuspended in 1/10th of the original volume. Concentrated
supernatants were immediately used to infect target cells or frozen and stored at
280 C˚ for later use. T cells were transduced with retroviral vectors 24 h (F5 CD8+
or CD4+ BALB/c T cells) or 48 h post activation (DO11.10 CD4+ T cells). CD4+
BALB/c T cells were transduced in the presence of Polybrene (0.5 mg/ml). CD4+ T
cells were ‘spinfected’ by centrifugation of the cells with the concentrated viral
supernatant at 2000 rpm for 1 h, whereas CD8+ T cells were cultured in the
presence of virus for 48 h.
Imaging of conjugates and microclusters
Formation of T cell-APC conjugates, imaging and analysis were performed as
described earlier (Saveliev et al., 2009). Cells were stained with antibodies to Vav1
(2502, Cell Signaling) and phosphotyrosine (4G10, Millipore). Polarisation of Vav1 or
phosphotyrosine was calculated as a recruitment index (RI) being the ratio of mean
fluorescence intensity (MFI) at the APC contact site versus the MFI of the rest of the
cell. For scoring the recruitment of molecules toward the APC, positive conjugates
were defined as those where the RI of the molecules in question was at least 1 standard
deviation (SD) greater than the mean RI in T cells conjugated to APCs bearing no
antigen. Imaging of live 5C.C7 CD4+ or P14 CD8+ T cells expressing EGFP-Vav1 and
subsequent classification of the patterns of accumulation of EGFP-Vav1 was carried
out using image processing as previously described (Singleton et al., 2009). 5C.C7 T
cells were conjugated with CH27 B cell lymphoma APCs pulsed with 10 mM MCC
agonist peptide. P14 T cells were conjugated with B cells from C57BL/6 mice that had
been activated for 3 days with anti-CD40 (0.5 mg/ml) and pulsed with 10 mM gp33
agonist peptide.
To image microcluster formation, activated T cells were stimulated for 3 min at
37 C˚ on coverslips (MatTek Corporation; P35G-1.5-10-C) previously coated with
anti-CD3e (2C11 clone) and in some cases also with anti-CD28 (37.51 clone)
antibodies (both at 10 mg/ml). Poly-L-lysine coated coverslips were used as a negative
control. Following stimulation, cells were fixed with 3% paraformaldehyde for 20 min
at room temperature, washed twice with PBS, and permeabilised with 0.3% Triton X-
100 in PBS for 2 min. Binding of primary and secondary antibodies was performed in
blocking solution [PBS containing 0.1% saponin (Sigma, S4521) and 0.25% gelatin
(Sigma, G7765)]. EGFP-Vav1 was detected using anti-GFP (chicken IgY, A10262,
Invitrogen) with goat anti-chicken IgY NL493 (NL018, R&D Systems) as a secondary
antibody. SLP76 was detected using an anti-SLP76 (rabbit polyclonal antibody, sc-
9062, Santa Cruz) with AF568 donkey anti-rabbit Ig (A10042, Invitrogen) as a
secondary antibody. TIRF imaging was carried out as previously described (Knipe
et al., 2010), using an Olympus UPLSAPO6100 1.40NA objective and a custom build
objective based TIRF system (Mashanov et al., 2003). Excitation light was provided
by a 20 mW 488 nm laser (Point Source, Hamble UK), and a 50 mW 561 nm laser
(GLC-050-561, CrystaLasers, Nevada, USA), and illumination was synchronised with
image capture using Winfluor software (http://spider.science.strath.ac.uk ). Analysis
was performed using ImageJ and JACoP software. Area fraction was calculated as
area of all clusters/area of cell.
Measurement of Ca2+ flux
Ca2+ flux in T cells labelled with PerCP-conjugated anti-CD4, anti-CD3e (10 mg/
ml), and Indo-1 am (2 mg/ml, Molecular Probes) was measured with LSRII flow
cytometers (BD Biosciences) as previously described (Reynolds et al., 2002). To
measure calcium release from intracellular stores without influx across the plasma
membrane, ethylene glycol-bis(2-aminoethylether)-N,N,N9,N9-tetraacetic acid
(EGTA, 10 mM) was added to the medium.
Immunoprecipitation and immunoblotting
Activated T cells were rested in proliferation medium without IL-2 for 5 h.
Stimulation of the cells through the TCR by cross-linking with antibodies against
CD3e (10 mg/ml) and CD28 (10 mg/ml) and subsequent immunoprecipitation and
immunoblotting were performed as described earlier (Reynolds et al., 2002). Vav1
was immunoprecipitated using an antibody against Vav1 (C-14, Santa Cruz). The
following antibodies were used for immunoblotting: anti-Vav1 (Cell Signaling,
2502), anti-Erk2 (sc-154, Santa Cruz Biotechnology), anti-phospho Erk2 (sc-7383,
Santa Cruz Biotechnology), anti-phosphotyrosine (4G10; Upstate Biotechnology),
Alexa Fluor-680 conjugated anti-mouse (Invitrogen; A21058) and IRDye800 anti-
rabbit (Rockland; 611-132-122). Signals were detected with an Odyssey Infrared
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Imager (Li-Cor Biotechnology) and analysed with the manufacturer’s software.
The degree of phosphorylation was determined as a ratio of the intensity of the
bands of phosphorylated proteins to those of total proteins. Each signal was
normalised to the phosphorylation signal of EGFP-Vav1 at 1 min, which was set to
100% and multiple experiments were combined to generate mean6SEM.
Expression and purification of recombinant proteins and isothermal
titration calorimetry (ITC)
Recombinant fragments of mouse Vav1 were expressed in E. coli. The SH2
domain (669–771) was expressed at 16 C˚ as a GST fusion from pGEX-6P1 (GE
Life Sciences), purified by GST affinity chromatography. After removal of the
GST-tag by PreScission Protease the protein was purified to homogeneity by gel
filtration. SH3A-SH2 (596–771) and SH2-SH3B (669–845) were expressed at
37 C˚ from pET28a (Novagen) with a His6-tag, and purified by nickel affinity and
gel filtration chromatography according to standard protocols. SH3-SH2-SH3B
(596–845) was expressed in a modified pET22b vector containing a biotinylation
site preceded by a PreScission Protease site at the C-terminus of the protein. The
protein was bound to streptavidin-coated beads (Pierce), incubated overnight with
protease and purified to homogeneity by gel filtration. All gel filtration was carried
out in ITC buffer (20 mM Hepes pH 7.5, 150 mM NaCl, 1 mM EDTA, 1 mM
TCEP), which was also used to re-suspend the peptides. Protein and peptide
concentrations were determined by absorbance at 280 nM. Peptides were
synthesised by W. Mawby, University of Bristol and contained the following
sequences: pY112: EDDpYESPND, pY128: DGDpYESPNE and
2pY:EDDpYESPNDDDPDGEDDGDpYESPNE. ITC experiments were performed
at 20 C˚ using an ITC-200 calorimeter (GE Life Sciences). Heats of dilution were
subtracted from the raw ITC data prior to analysis with the software, Micro Origin
version 7.0, assuming a single-site binding model.
Statistical analysis
All statistical comparisons were carried out using the nonparametric two-tailed
Mann–Whitney test, an unpaired two-tailed t-test, or Fisher’s exact test.
Statistically significant differences are indicated on the figures: *P,0.05,
**P,0.01, ***P,0.001.
Acknowledgements
We thank Agnieszka Zachacz for expert assistance, Edina
Schweighoffer for help in generation of chimeric mice and Daniel
Billadeau, Steve Smerdon and Gary Koretzky for advice.
Funding
M.F. was a recipient of an EMBO long-term fellowship (fellowship
number ALTF 508-2005) and a EU Marie Curie fellowship.
(fellowship number EIF 025449). O.K., A.S., J.R., K.R., T.C. and
V.T. were funded by the UK Medical Research Council programme
[grant numbers U117527252, U117565398 and U117573808]; R.K.
was supported by Wellcome Trust [grant number 089185]. Deposited
in PMC for immediate release.
Supplementary material available online at
http://jcs.biologists.org/lookup/suppl/doi:10.1242/jcs.105148/-/DC1
References
Aghazadeh, B., Lowry, W. E., Huang, X. Y. and Rosen, M. K. (2000). Structural basis
for relief of autoinhibition of the Dbl homology domain of proto-oncogene Vav by
tyrosine phosphorylation. Cell 102, 625-633.
Ardouin, L., Bracke, M., Mathiot, A., Pagakis, S. N., Norton, T., Hogg, N. and
Tybulewicz, V. L. J. (2003). Vav1 transduces TCR signals required for LFA-1
function and cell polarization at the immunological synapse. Eur. J. Immunol. 33,
790-797.
Barda-Saad, M., Braiman, A., Titerence, R., Bunnell, S. C., Barr, V. A. and
Samelson, L. E. (2005). Dynamic molecular interactions linking the T cell antigen
receptor to the actin cytoskeleton. Nat. Immunol. 6, 80-89.
Barda-Saad, M., Shirasu, N., Pauker, M. H., Hassan, N., Perl, O., Balbo, A.,
Yamaguchi, H., Houtman, J. C., Appella, E., Schuck, P. et al. (2010). Cooperative
interactions at the SLP-76 complex are critical for actin polymerization. EMBO J. 29,
2315-2328.
Beal, A. M., Anikeeva, N., Varma, R., Cameron, T. O., Vasiliver-Shamis, G., Norris,
P. J., Dustin, M. L. and Sykulev, Y. (2009). Kinetics of early T cell receptor
signaling regulate the pathway of lytic granule delivery to the secretory domain.
Immunity 31, 632-642.
Bertagnolo, V., Marchisio, M., Volinia, S., Caramelli, E. and Capitani, S. (1998).
Nuclear association of tyrosine-phosphorylated Vav to phospholipase C-gamma1 and
phosphoinositide 3-kinase during granulocytic differentiation of HL-60 cells. FEBS
Lett. 441, 480-484.
Blanchet, F., Cardona, A., Letimier, F. A., Hershfield, M. S. and Acuto, O. (2005).
CD28 costimulatory signal induces protein arginine methylation in T cells. J. Exp.
Med. 202, 371-377.
Braiman, A., Barda-Saad, M., Sommers, C. L. and Samelson, L. E. (2006).
Recruitment and activation of PLCgamma1 in T cells: a new insight into old domains.
EMBO J. 25, 774-784.
Brugnoli, F., Lambertini, E., Varin-Blank, N., Piva, R., Marchisio, M., Grassilli, S.,
Miscia, S., Capitani, S. and Bertagnolo, V. (2010). Vav1 and PU.1 are recruited to
the CD11b promoter in APL-derived promyelocytes: role of Vav1 in modulating
PU.1-containing complexes during ATRA-induced differentiation. Exp. Cell Res.
316, 38-47.
Bunnell, S. C., Diehn, M., Yaffe, M. B., Findell, P. R., Cantley, L. C. and Berg, L. J.
(2000). Biochemical interactions integrating Itk with the T cell receptor-initiated
signaling cascade. J. Biol. Chem. 275, 2219-2230.
Bunnell, S. C., Kapoor, V., Trible, R. P., Zhang, W. and Samelson, L. E. (2001).
Dynamic actin polymerization drives T cell receptor-induced spreading: a role for the
signal transduction adaptor LAT. Immunity 14, 315-329.
Bunnell, S. C., Hong, D. I., Kardon, J. R., Yamazaki, T., McGlade, C. J., Barr, V. A.
and Samelson, L. E. (2002). T cell receptor ligation induces the formation of
dynamically regulated signaling assemblies. J. Cell Biol. 158, 1263-1275.
Bunnell, S. C., Singer, A. L., Hong, D. I., Jacque, B. H., Jordan, M. S., Seminario,
M.-C., Barr, V. A., Koretzky, G. A. and Samelson, L. E. (2006). Persistence of
cooperatively stabilized signaling clusters drives T-cell activation. Mol. Cell. Biol. 26,
7155-7166.
Campi, G., Varma, R. and Dustin, M. L. (2005). Actin and agonist MHC-peptide
complex-dependent T cell receptor microclusters as scaffolds for signaling. J. Exp.
Med. 202, 1031-1036.
Chrencik, J. E., Brooun, A., Zhang, H., Mathews, I. I., Hura, G. L., Foster, S. A.,
Perry, J. J., Streiff, M., Ramage, P., Widmer, H. et al. (2008). Structural basis of
guanine nucleotide exchange mediated by the T-cell essential Vav1. J. Mol. Biol. 380,
828-843.
Clevenger, C. V., Ngo, W., Sokol, D. L., Luger, S. M. and Gewirtz, A. M. (1995).
Vav is necessary for prolactin-stimulated proliferation and is translocated into the
nucleus of a T-cell line. J. Biol. Chem. 270, 13246-13253.
Costello, P. S., Walters, A. E., Mee, P. J., Turner, M., Reynolds, L. F., Prisco, A.,
Sarner, N., Zamoyska, R. and Tybulewicz, V. L. J. (1999). The Rho-family GTP
exchange factor Vav is a critical transducer of T cell receptor signals to the calcium,
ERK, and NF-kappaB pathways. Proc. Natl. Acad. Sci. USA 96, 3035-3040.
Dombroski, D., Houghtling, R. A., Labno, C. M., Precht, P., Takesono, A., Caplen,
N. J., Billadeau, D. D., Wange, R. L., Burkhardt, J. K. and Schwartzberg, P. L.
(2005). Kinase-independent functions for Itk in TCR-induced regulation of Vav and
the actin cytoskeleton. J. Immunol. 174, 1385-1392.
Dustin, M. L., Olszowy, M. W., Holdorf, A. D., Li, J., Bromley, S., Desai, N.,
Widder, P., Rosenberger, F., van der Merwe, P. A., Allen, P. M. et al. (1998). A
novel adaptor protein orchestrates receptor patterning and cytoskeletal polarity in T-
cell contacts. Cell 94, 667-677.
Dustin, M. L., Chakraborty, A. K. and Shaw, A. S. (2010). Understanding the
structure and function of the immunological synapse. Cold Spring Harb. Perspect.
Biol. 2, a002311.
Fang, N. and Koretzky, G. A. (1999). SLP-76 and Vav function in separate, but
overlapping pathways to augment interleukin-2 promoter activity. J. Biol. Chem. 274,
16206-16212.
Fischer, K.-D., Kong, Y.-Y., Nishina, H., Tedford, K., Marenge`re, L. E. M.,
Kozieradzki, I., Sasaki, T., Starr, M., Chan, G., Gardener, S. et al. (1998). Vav is
a regulator of cytoskeletal reorganization mediated by the T-cell receptor. Curr. Biol.
8, 554-562.
Grakoui, A., Bromley, S. K., Sumen, C., Davis, M. M., Shaw, A. S., Allen, P. M. and
Dustin, M. L. (1999). The immunological synapse: a molecular machine controlling
T cell activation. Science 285, 221-227.
Groysman, M., Hornstein, I., Alcover, A. and Katzav, S. (2002). Vav1 and Ly-GDI
two regulators of Rho GTPases, function cooperatively as signal transducers in T cell
antigen receptor-induced pathways. J. Biol. Chem. 277, 50121-50130.
Han, J., Luby-Phelps, K., Das, B., Shu, X., Xia, Y., Mosteller, R. D., Krishna, U. M.,
Falck, J. R., White, M. A. and Broek, D. (1998). Role of substrates and products of
PI 3-kinase in regulating activation of Rac-related guanosine triphosphatases by Vav.
Science 279, 558-560.
Holsinger, L. J., Graef, I. A., Swat, W., Chi, T., Bautista, D. M., Davidson, L., Lewis,
R. S., Alt, F. W. and Crabtree, G. R. (1998). Defects in actin-cap formation in Vav-
deficient mice implicate an actin requirement for lymphocyte signal transduction.
Curr. Biol. 8, 563-572.
Houlard, M., Arudchandran, R., Regnier-Ricard, F., Germani, A., Gisselbrecht, S.,
Blank, U., Rivera, J. and Varin-Blank, N. (2002). Vav1 is a component of
transcriptionally active complexes. J. Exp. Med. 195, 1115-1127.
Jenkins, M. R., Tsun, A., Stinchcombe, J. C. and Griffiths, G. M. (2009). The
strength of T cell receptor signal controls the polarization of cytotoxic machinery to
the immunological synapse. Immunity 31, 621-631.
Jordan, M. S., Smith, J. E., Burns, J. C., Austin, J. E., Nichols, K. E.,
Aschenbrenner, A. C. and Koretzky, G. A. (2008). Complementation in trans of
altered thymocyte development in mice expressing mutant forms of the adaptor
molecule SLP76. Immunity 28, 359-369.
Katzav, S., Sutherland, M., Packham, G., Yi, T. and Weiss, A. (1994). The protein
tyrosine kinase ZAP-70 can associate with the SH2 domain of proto-Vav. J. Biol.
Chem. 269, 32579-32585.
Vav1 localisation and function 5313
J
o
u
rn
a
l
o
f
C
e
ll
S
c
ie
n
c
e
Knipe, L., Meli, A., Hewlett, L., Bierings, R., Dempster, J., Skehel, P., Hannah,
M. J. and Carter, T. (2010). A revised model for the secretion of tPA and cytokines
from cultured endothelial cells. Blood 116, 2183-2191.
Koretzky, G. A., Abtahian, F. and Silverman, M. A. (2006). SLP76 and SLP65:
complex regulation of signalling in lymphocytes and beyond. Nat. Rev. Immunol. 6,
67-78.
Krawczyk, C., Oliveira-dos-Santos, A., Sasaki, T., Griffiths, E., Ohashi, P. S.,
Snapper, S., Alt, F. and Penninger, J. M. (2002). Vav1 controls integrin clustering
and MHC/peptide-specific cell adhesion to antigen-presenting cells. Immunity 16,
331-343.
Lemmon, M. A. (2008). Membrane recognition by phospholipid-binding domains. Nat.
Rev. Mol. Cell Biol. 9, 99-111.
Mamalaki, C., Elliott, J., Norton, T., Yannoutsos, N., Townsend, A. R., Chandler,
P., Simpson, E. and Kioussis, D. (1993). Positive and negative selection in
transgenic mice expressing a T-cell receptor specific for influenza nucleoprotein and
endogenous superantigen. Dev. Immunol. 3, 159-174.
Mashanov, G. I., Tacon, D., Knight, A. E., Peckham, M. and Molloy, J. E. (2003).
Visualizing single molecules inside living cells using total internal reflection
fluorescence microscopy. Methods 29, 142-152.
Michel, F., Mangino, G., Attal-Bonnefoy, G., Tuosto, L., Alcover, A., Roumier, A.,
Olive, D. and Acuto, O. (2000). CD28 utilizes Vav-1 to enhance TCR-proximal
signaling and NF-AT activation. J. Immunol. 165, 3820-3829.
Miletic, A. V., Sakata-Sogawa, K., Hiroshima, M., Hamann, M. J., Gomez, T. S.,
Ota, N., Kloeppel, T., Kanagawa, O., Tokunaga, M., Billadeau, D. D. et al. (2006).
Vav1 acidic region tyrosine 174 is required for the formation of T cell receptor-
induced microclusters and is essential in T cell development and activation. J. Biol.
Chem. 281, 38257-38265.
Miletic, A. V., Graham, D. B., Sakata-Sogawa, K., Hiroshima, M., Hamann, M. J.,
Cemerski, S., Kloeppel, T., Billadeau, D. D., Kanagawa, O., Tokunaga, M. et al.
(2009). Vav links the T cell antigen receptor to the actin cytoskeleton and T cell
activation independently of intrinsic Guanine nucleotide exchange activity. PLoS
ONE 4, e6599.
Monks, C. R. F., Freiberg, B. A., Kupfer, H., Sciaky, N. and Kupfer, A. (1998).
Three-dimensional segregation of supramolecular activation clusters in T cells.
Nature 395, 82-86.
Morita, S., Kojima, T. and Kitamura, T. (2000). Plat-E: an efficient and stable system
for transient packaging of retroviruses. Gene Ther. 7, 1063-1066.
Mossman, K. D., Campi, G., Groves, J. T. and Dustin, M. L. (2005). Altered TCR
signaling from geometrically repatterned immunological synapses. Science 310,
1191-1193.
Murphy, K. M., Heimberger, A. B. and Loh, D. Y. (1990). Induction by antigen of
intrathymic apoptosis of CD4+CD8+TCRlo thymocytes in vivo. Science 250, 1720-
1723.
Nishida, M., Nagata, K., Hachimori, Y., Horiuchi, M., Ogura, K., Mandiyan, V.,
Schlessinger, J. and Inagaki, F. (2001). Novel recognition mode between Vav and
Grb2 SH3 domains. EMBO J. 20, 2995-3007.
Nunes, J. A., Battifora, M., Woodgett, J. R., Truneh, A., Olive, D. and Cantrell,
D. A. (1996). CD28 signal transduction pathways. A comparison of B7-1 and B7-2
regulation of the map kinases: ERK2 and Jun kinases. Mol. Immunol. 33, 63-70.
O’Keefe, J. P., Blaine, K., Alegre, M. L. and Gajewski, T. F. (2004). Formation of a
central supramolecular activation cluster is not required for activation of naive CD8+
T cells. Proc. Natl. Acad. Sci. USA 101, 9351-9356.
Pircher, H., Bu¨rki, K., Lang, R., Hengartner, H. and Zinkernagel, R. M. (1989).
Tolerance induction in double specific T-cell receptor transgenic mice varies with
antigen. Nature 342, 559-561.
Prisco, A., Vanes, L., Ruf, S., Trigueros, C. and Tybulewicz, V. L. J. (2005). Lineage-
specific requirement for the PH domain of Vav1 in the activation of CD4+ but not
CD8+ T cells. Immunity 23, 263-274.
Raab, M., Pfister, S. and Rudd, C. E. (2001). CD28 signaling via VAV/SLP-76
adaptors: regulation of cytokine transcription independent of TCR ligation. Immunity
15, 921-933.
Rapley, J., Tybulewicz, V. L. and Rittinger, K. (2008). Crucial structural role for the
PH and C1 domains of the Vav1 exchange factor. EMBO Rep. 9, 655-661.
Reynolds, L. F., Smyth, L. A., Norton, T., Freshney, N., Downward, J., Kioussis, D.
and Tybulewicz, V. L. J. (2002). Vav1 transduces T cell receptor signals to the
activation of phospholipase C-c1 via phosphoinositide 3-kinase-dependent and -
independent pathways. J. Exp. Med. 195, 1103-1114.
Reynolds, L. F., de Bettignies, C., Norton, T., Beeser, A., Chernoff, J. and
Tybulewicz, V. L. J. (2004). Vav1 transduces T cell receptor signals to the activation
of the Ras/ERK pathway via LAT, Sos, and RasGRP1. J. Biol. Chem. 279, 18239-
18246.
Romero, F., Dargemont, C., Pozo, F., Reeves, W. H., Camonis, J., Gisselbrecht, S.
and Fischer, S. (1996). p95vav associates with the nuclear protein Ku-70. Mol. Cell.
Biol. 16, 37-44.
Romero, F., Germani, A., Puvion, E., Camonis, J., Varin-Blank, N., Gisselbrecht, S.
and Fischer, S. (1998). Vav binding to heterogeneous nuclear ribonucleoprotein
(hnRNP) C. Evidence for Vav-hnRNP interactions in an RNA-dependent manner.
J. Biol. Chem. 273, 5923-5931.
Saveliev, A., Vanes, L., Ksionda, O., Rapley, J., Smerdon, S. J., Rittinger, K. and
Tybulewicz, V. L. (2009). Function of the nucleotide exchange activity of vav1 in T
cell development and activation. Sci. Signal. 2, ra83.
Seder, R. A., Paul, W. E., Davis, M. M. and Fazekas de St Groth, B. (1992). The
presence of interleukin 4 during in vitro priming determines the lymphokine-
producing potential of CD4+ T cells from T cell receptor transgenic mice. J. Exp.
Med. 176, 1091-1098.
Singleton, K. L., Roybal, K. T., Sun, Y., Fu, G., Gascoigne, N. R., van Oers, N. S.
and Wu¨lfing, C. (2009). Spatiotemporal patterning during T cell activation is highly
diverse. Sci. Signal. 2, ra15.
Singleton, K. L., Gosh, M., Dandekar, R. D., Au-Yeung, B. B., Ksionda, O.,
Tybulewicz, V. L., Altman, A., Fowell, D. J. and Wu¨lfing, C. (2011). Itk controls
the spatiotemporal organization of T cell activation. Sci. Signal. 4, ra66.
Songyang, Z., Shoelson, S. E., McGlade, J., Olivier, P., Pawson, T., Bustelo, X. R.,
Barbacid, M., Sabe, H., Hanafusa, H., Yi, T. et al. (1994). Specific motifs
recognized by the SH2 domains of Csk, 3BP2, fps/fes, GRB-2, HCP, SHC, Syk, and
Vav. Mol. Cell. Biol. 14, 2777-2785.
Spanopoulou, E., Roman, C. A., Corcoran, L. M., Schlissel, M. S., Silver, D. P.,
Nemazee, D., Nussenzweig, M. C., Shinton, S. A., Hardy, R. R. and Baltimore, D.
(1994). Functional immunoglobulin transgenes guide ordered B-cell differentiation in
Rag-1-deficient mice. Genes Dev. 8, 1030-1042.
Stinchcombe, J. C., Bossi, G., Booth, S. and Griffiths, G. M. (2001). The
immunological synapse of CTL contains a secretory domain and membrane bridges.
Immunity 15, 751-761.
Sylvain, N. R., Nguyen, K. and Bunnell, S. C. (2011). Vav1-mediated scaffolding
interactions stabilize SLP-76 microclusters and contribute to antigen-dependent T cell
responses. Sci. Signal. 4, ra14.
Tamir, A., Eisenbraun, M. D., Garcia, G. G. and Miller, R. A. (2000). Age-dependent
alterations in the assembly of signal transduction complexes at the site of T cell/APC
interaction. J. Immunol. 165, 1243-1251.
Tuosto, L., Michel, F. and Acuto, O. (1996). p95vav associates with tyrosine-
phosphorylated SLP-76 in antigen-stimulated T cells. J. Exp. Med. 184, 1161-1166.
Turner, M., Mee, P. J., Walters, A. E., Quinn, M. E., Mellor, A. L., Zamoyska, R.
and Tybulewicz, V. L. J. (1997). A requirement for the Rho-family GTP exchange
factor Vav in positive and negative selection of thymocytes. Immunity 7, 451-460.
Tybulewicz, V. L. J. (2005). Vav-family proteins in T-cell signalling. Curr. Opin.
Immunol. 17, 267-274.
Varma, R., Campi, G., Yokosuka, T., Saito, T. and Dustin, M. L. (2006). T cell
receptor-proximal signals are sustained in peripheral microclusters and terminated in
the central supramolecular activation cluster. Immunity 25, 117-127.
Villalba, M., Bi, K., Rodriguez, F., Tanaka, Y., Schoenberger, S. and Altman, A.
(2001). Vav1/Rac-dependent actin cytoskeleton reorganization is required for lipid
raft clustering in T cells. J. Cell Biol. 155, 331-338.
Wu, J., Motto, D. G., Koretzky, G. A. and Weiss, A. (1996). Vav and SLP-76 interact
and functionally cooperate in IL-2 gene activation. Immunity 4, 593-602.
Wu, J., Zhao, Q., Kurosaki, T. and Weiss, A. (1997). The Vav binding site (Y315) in
ZAP-70 is critical for antigen receptor-mediated signal transduction. J. Exp. Med.
185, 1877-1882.
Wu¨lfing, C., Bauch, A., Crabtree, G. R. and Davis, M. M. (2000). The vav exchange
factor is an essential regulator in actin-dependent receptor translocation to the
lymphocyte-antigen-presenting cell interface. Proc. Natl. Acad. Sci. USA 97, 10150-
10155.
Xavier, R., Brennan, T., Li, Q., McCormack, C. and Seed, B. (1998). Membrane
compartmentation is required for efficient T cell activation. Immunity 8, 723-732.
Yokosuka, T., Sakata-Sogawa, K., Kobayashi, W., Hiroshima, M., Hashimoto-Tane,
A., Tokunaga, M., Dustin, M. L. and Saito, T. (2005). Newly generated T cell
receptor microclusters initiate and sustain T cell activation by recruitment of Zap70
and SLP-76. Nat. Immunol. 6, 1253-1262.
Yu, B., Martins, I. R., Li, P., Amarasinghe, G. K., Umetani, J., Fernandez-Zapico,
M. E., Billadeau, D. D., Machius, M., Tomchick, D. R. and Rosen, M. K. (2010).
Structural and energetic mechanisms of cooperative autoinhibition and activation of
Vav1. Cell 140, 246-256.
Zeng, R., Cannon, J. L., Abraham, R. T., Way, M., Billadeau, D. D., Bubeck-
Wardenberg, J. and Burkhardt, J. K. (2003). SLP-76 coordinates Nck-dependent
Wiskott-Aldrich syndrome protein recruitment with Vav-1/Cdc42-dependent
Wiskott-Aldrich syndrome protein activation at the T cell-APC contact site.
J. Immunol. 171, 1360-1368.
Zhang, W., Trible, R. P. and Samelson, L. E. (1998). LAT palmitoylation: its essential
role in membrane microdomain targeting and tyrosine phosphorylation during T cell
activation. Immunity 9, 239-246.
Journal of Cell Science 125 (22)5314
